{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:20:39Z","timestamp":1762917639469},"reference-count":54,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"crossref","award":["TMU100-AE1-B13"],"award-info":[{"award-number":["TMU100-AE1-B13"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Ovarian cancer has a poor prognosis. Most patients are diagnosed with ovarian cancer when the disease has reached an advanced stage and cure rates are generally under 30%. Hence, early diagnosis of ovarian cancer is the best means to control the disease in the long term and abate mortality. So far, cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) are the gold-standard tumor markers for ovarian cancer; however, these two markers can be elevated in a number of conditions unrelated to ovarian cancer, resulting in decreased specifically and positive predictive value. Therefore, it is urgent to identify novel biomarkers with high reliability and sensitivity for ovarian cancer. In this study for the first time, we identified a member of the centromere protein (CENP) family, CENPK, which was specifically upregulated in ovarian cancer tissues and cell lines and the overexpression of which was associated with poor prognoses in patients with ovarian cancer. In addition, the presence of CENPK significantly improved the sensitivity of CA125 or HE4 for predicting clinical outcomes of ovarian cancer patients. In conclusion, we identified that CENPK was specifically upregulated in ovarian cancer cells and can be used as a novel tumor marker of ovarian cancer.<\/jats:p>","DOI":"10.7717\/peerj.1386","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T09:50:12Z","timestamp":1446717012000},"page":"e1386","source":"Crossref","is-referenced-by-count":33,"title":["Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance"],"prefix":"10.7717","volume":"3","author":[{"given":"Yi-Chao","family":"Lee","sequence":"first","affiliation":[{"name":"Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chen","family":"Huang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-Yen","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan"},{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chang","family":"Chang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuen-Haur","family":"Lee","sequence":"additional","affiliation":[{"name":"Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"10.7717\/peerj.1386\/ref-1","doi-asserted-by":"publisher","first-page":"e74250","DOI":"10.1371\/journal.pone.0074250","article-title":"SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis","volume":"8","author":"Aguirre-Gamboa","year":"2013","journal-title":"PLoS ONE"},{"key":"10.7717\/peerj.1386\/ref-2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1083\/jcb.200903100","article-title":"The CENP-S complex is essential for the stable assembly of outer kinetochore structure","volume":"186","author":"Amano","year":"2009","journal-title":"Journal of Cell Biology"},{"key":"10.7717\/peerj.1386\/ref-3","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-119","article-title":"CENPA overexpression promotes genome instability in pRb-depleted human cells","volume":"8","author":"Amato","year":"2009","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.1386\/ref-4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"British Journal of Cancer"},{"key":"10.7717\/peerj.1386\/ref-5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nature Reviews Cancer"},{"key":"10.7717\/peerj.1386\/ref-6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.molcel.2006.12.018","article-title":"Centromere identity maintained by nucleosomes assembled with histone H3 containing the CENP-A targeting domain","volume":"25","author":"Black","year":"2007","journal-title":"Molecular Cell"},{"key":"10.7717\/peerj.1386\/ref-7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/44062","article-title":"A histone-H3-like protein in C. elegans","volume":"401","author":"Buchwitz","year":"1999","journal-title":"Nature"},{"key":"10.7717\/peerj.1386\/ref-8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4331\/wjbc.v5.i3.286","article-title":"In 2014, can we do better than CA125 in the early detection of ovarian cancer?","volume":"5","author":"Cohen","year":"2014","journal-title":"World Journal of Biological Chemistry"},{"key":"10.7717\/peerj.1386\/ref-9","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.1158\/0008-5472.CAN-06-1968","article-title":"A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition","volume":"66","author":"Cristiano","year":"2006","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.1386\/ref-10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/boc.201400096","article-title":"Detecting and targeting oncogenic fusion proteins in the genomic era","volume":"107","author":"Davare","year":"2015","journal-title":"Biology of the Cell"},{"key":"10.7717\/peerj.1386\/ref-11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clinical Chemistry"},{"key":"10.7717\/peerj.1386\/ref-12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrc1041","article-title":"The case for early detection","volume":"3","author":"Etzioni","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"10.7717\/peerj.1386\/ref-13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Modern Pathology"},{"key":"10.7717\/peerj.1386\/ref-14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nature10973","article-title":"An inverse relationship to germline transcription defines centromeric chromatin in C. elegans","volume":"484","author":"Gassmann","year":"2012","journal-title":"Nature"},{"key":"10.7717\/peerj.1386\/ref-15","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1101\/gr.2596504","article-title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)","volume":"14","author":"Gerhard","year":"2004","journal-title":"Genome Research"},{"key":"10.7717\/peerj.1386\/ref-16","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/jcb.21766","article-title":"Centromeres in cell division, evolution, nuclear organization and disease","volume":"104","author":"Goncalves Dos Santos Silva","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.7717\/peerj.1386\/ref-17","first-page":"1420","article-title":"Activation and overexpression of centrosome kinase BTAK\/Aurora-A in human ovarian cancer","volume":"9","author":"Gritsko","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.7717\/peerj.1386\/ref-18","first-page":"107","article-title":"Carcinoma of the ovary","volume":"6","author":"Heintz","year":"2001","journal-title":"Journal of Epidemiology and Biostatistics"},{"key":"10.7717\/peerj.1386\/ref-19","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.1386\/ref-20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergencyto.2006.04.010","article-title":"Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors","volume":"170","author":"Helou","year":"2006","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.7717\/peerj.1386\/ref-21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1091\/mbc.E07-06-0556","article-title":"CENP-O class proteins form a stable complex and are required for proper kinetochore function","volume":"19","author":"Hori","year":"2008","journal-title":"Molecular Biology of the Cell"},{"key":"10.7717\/peerj.1386\/ref-22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1073\/pnas.97.3.1148","article-title":"Early disruption of centromeric chromatin organization in centromere protein A (Cenpa) null mice","volume":"97","author":"Howman","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.1386\/ref-23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2443.2006.00969.x","article-title":"Comprehensive analysis of the ICEN (Interphase Centromere Complex) components enriched in the CENP-A chromatin of human cells","volume":"11","author":"Izuta","year":"2006","journal-title":"Genes to Cells"},{"key":"10.7717\/peerj.1386\/ref-24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/gcc.2870100403","article-title":"Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors","volume":"10","author":"Kallioniemi","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.7717\/peerj.1386\/ref-25","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/1055-9965","article-title":"Biomarkers for screening, diagnosis, and monitoring of ovarian cancer","volume":"21","author":"Kobayashi","year":"2012","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.7717\/peerj.1386\/ref-26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc1714","article-title":"On the road to cancer: aneuploidy and the mitotic checkpoint","volume":"5","author":"Kops","year":"2005","journal-title":"Nature Reviews Cancer"},{"key":"10.7717\/peerj.1386\/ref-27","doi-asserted-by":"publisher","first-page":"e17794","DOI":"10.1371\/journal.pone.0017794","article-title":"ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"10.7717\/peerj.1386\/ref-28","doi-asserted-by":"publisher","first-page":"R72","DOI":"10.1186\/bcr3181","article-title":"Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer","volume":"14","author":"McGovern","year":"2012","journal-title":"Breast Cancer Research"},{"key":"10.7717\/peerj.1386\/ref-29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1471-2407-14-315","article-title":"Genomic profile of ovarian carcinomas","volume":"14","author":"Micci","year":"2014","journal-title":"BMC Cancer"},{"issue":"Spec No","key":"10.7717\/peerj.1386\/ref-30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ng0497supp-417","article-title":"A breakpoint map of recurrent chromosomal rearrangements in human neoplasia","volume":"15","author":"Mitelman","year":"1997","journal-title":"Nature Genetics"},{"key":"10.7717\/peerj.1386\/ref-31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0090-8258(03)00254-3","article-title":"Ovarian cancer and high-risk women-implications for prevention, screening, and early detection","volume":"91","author":"Modugno","year":"2003","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.1386\/ref-32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ccr.2009.10.018","article-title":"A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2","volume":"16","author":"Mok","year":"2009","journal-title":"Cancer Cell"},{"key":"10.7717\/peerj.1386\/ref-33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.1386\/ref-34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.1386\/ref-35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"Nagy","year":"2012","journal-title":"Annals of Clinical Biochemistry"},{"key":"10.7717\/peerj.1386\/ref-36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ygyno.2010.02.005","article-title":"Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass","volume":"117","author":"Nolen","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.7717\/peerj.1386\/ref-37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/ncb1396","article-title":"The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres","volume":"8","author":"Okada","year":"2006","journal-title":"Nature Cell Biology"},{"key":"10.7717\/peerj.1386\/ref-38","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Munoz","year":"2014","journal-title":"Tumour Biology"},{"key":"10.7717\/peerj.1386\/ref-39","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.clinbiochem.2011.04.011","article-title":"Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases","volume":"44","author":"Park","year":"2011","journal-title":"Clinical Biochemistry"},{"key":"10.7717\/peerj.1386\/ref-40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00412-011-0330-0","article-title":"The ABCs of CENPs","volume":"120","author":"Perpelescu","year":"2011","journal-title":"Chromosoma"},{"key":"10.7717\/peerj.1386\/ref-41","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s13277-013-0860-6","article-title":"Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer","volume":"34","author":"Qiu","year":"2013","journal-title":"Tumour Biology"},{"key":"10.7717\/peerj.1386\/ref-42","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1038\/onc.2011.539","article-title":"A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer","volume":"31","author":"Ratner","year":"2012","journal-title":"Oncogene"},{"key":"10.7717\/peerj.1386\/ref-43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/cm.970260305","article-title":"CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization","volume":"26","author":"Rattner","year":"1993","journal-title":"Cell Motility and the Cytoskeleton"},{"key":"10.7717\/peerj.1386\/ref-44","first-page":"15","article-title":"Ovarian cancer screening and early detection in the general population","volume":"4","author":"Rauh-Hain","year":"2011","journal-title":"Reviews in Obstetrics & Gynecology"},{"key":"10.7717\/peerj.1386\/ref-45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S0009840X13002084","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.1386\/ref-46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S0009840X14001668","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.1386\/ref-47","first-page":"548","article-title":"The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas","volume":"27","author":"Simmons","year":"2013","journal-title":"Oncology"},{"key":"10.7717\/peerj.1386\/ref-48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.clinbiochem.2007.07.002","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure","volume":"41","author":"Tang","year":"2008","journal-title":"Clinical Biochemistry"},{"key":"10.7717\/peerj.1386\/ref-49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1593\/neo.91438","article-title":"c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1\/2","volume":"12","author":"Tang","year":"2010","journal-title":"Neoplasia"},{"key":"10.7717\/peerj.1386\/ref-50","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/gcc.20676","article-title":"Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival","volume":"48","author":"Thomassen","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.7717\/peerj.1386\/ref-51","first-page":"3511","article-title":"Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer","volume":"63","author":"Tomonaga","year":"2003","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.1386\/ref-52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.lungcan.2012.04.007","article-title":"Expression and prognostic significance of centromere protein A in human lung adenocarcinoma","volume":"77","author":"Wu","year":"2012","journal-title":"Lung Cancer"},{"key":"10.7717\/peerj.1386\/ref-53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/j.1460-2075.1991.tb08066.x","article-title":"CENP-E, a novel human centromere-associated protein required for progression from metaphase to anaphase","volume":"10","author":"Yen","year":"1991","journal-title":"EMBO Journal"},{"key":"10.7717\/peerj.1386\/ref-54","doi-asserted-by":"publisher","first-page":"27371","DOI":"10.1074\/jbc.M103554200","article-title":"Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16","volume":"276","author":"Yin","year":"2001","journal-title":"Journal of Biological Chemistry"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/1386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/1386.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/1386.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/1386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T08:28:32Z","timestamp":1567326512000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/1386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":54,"alternative-id":["10.7717\/peerj.1386"],"URL":"https:\/\/doi.org\/10.7717\/peerj.1386","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]},"article-number":"e1386"}}